Industry Specific Issues

R&D Tax Incentive Deadline Looms

March 17th, 2016

‘Innovation’, the term alone has somewhat formed a place in the Australian vernacular in recent months. The buzzword skyrocketed into popularity when Prime Minister Malcolm Turnbull issued its National Innovation and Science Agenda in December, detailing plans to increase innovation, entrepreneurship and reward risk tasking. Thus, with Australia embarking on an ‘ideas boom’ in 2016, the role of research and development (R&D) may become pivotal to businesses in the private sector. With this in mind, when it comes to government incentives […]

Read More

Biotech Firms Warn Against Changes to the R&D Tax Incentive

March 14th, 2016

There is a pervading fear in Australia that our best and brightest are failing to find opportunities locally and are instead vying for work overseas. ‘Brain Drain’, as it’s coined in public discourse, has subsequently become one of the key concerns for the Australian Government. Thus, as a response to dwindling innovation levels and in attempts to reverse the ‘brain drain’, the Australian government released the National Innovation and Science Agenda in December last year. In launching the agenda, the […]

Read More

App Developers, Have You Considered the R&D Tax Incentive?

March 11th, 2016

By 2020, 70 percent of the population will have smartphones. Accordingly, the dominant presence of smartphones is greatly expanding the scope of mobile phone software development. The “App Economy”, as it is branded, is indeed mounting as it intertwines with the phenomenal increase in mobile phone penetration. As a result, mobile application development has emerged as a leading category in the software industry. Typically, the development of this unique software for both iOS and Android platforms often requires extensive research […]

Read More

Policy Changes: Driving Innovation or a Reaction to Trends?

March 9th, 2016

Using the medical technology (medtech) industry as an example, we pose the question: do policy changes fuel innovation, or are they merely a reaction to emerging trends?  Over the last three decades, medical technologies have transformed many previously untreatable diseases into manageable long-term conditions. However, as the global disease burden evolves there is a continuing need to develop new and more effective medicines.  As a result, companies operating at the intersection of technology and medical science are attracting increasing attention as […]

Read More

Email this job